Fibrin Clot Formation under Oxidative Stress Conditions.
acute coronary syndrome
artery stenosis
fibrinogen
oxidative stress
stroke
Journal
Antioxidants (Basel, Switzerland)
ISSN: 2076-3921
Titre abrégé: Antioxidants (Basel)
Pays: Switzerland
ID NLM: 101668981
Informations de publication
Date de publication:
07 Jun 2021
07 Jun 2021
Historique:
received:
12
05
2021
revised:
02
06
2021
accepted:
04
06
2021
entrez:
2
7
2021
pubmed:
3
7
2021
medline:
3
7
2021
Statut:
epublish
Résumé
During coagulation, the soluble fibrinogen is converted into insoluble fibrin. Fibrinogen is a multifunctional plasma protein, which is essential for hemostasis. Various oxidative posttranslational modifications influence fibrinogen structure as well as interactions between various partners in the coagulation process. The aim was to examine the effects of oxidative stress conditions on fibrin clot formation in arterial atherothrombotic disorders. We studied the changes in in vitro fibrin network formation in three groups of patients-with acute coronary syndrome (ACS), with significant carotid artery stenosis (SCAS), and with acute ischemic stroke (AIS), as well as a control group. The level of oxidative stress marker malondialdehyde measured by LC-MS/MS was higher in SCAS and AIS patients compared with controls. Turbidic methods revealed a higher final optical density and a prolonged lysis time in the clots of these patients. Electron microscopy was used to visualize changes in the in vitro-formed fibrin network. Fibers from patients with AIS were significantly thicker in comparison with control and ACS fibers. The number of fibrin fibers in patients with AIS was significantly lower in comparison with ACS and control groups. Thus, oxidative stress-mediated changes in fibrin clot formation, structure and dissolution may affect the effectiveness of thrombolytic therapy.
Identifiants
pubmed: 34200255
pii: antiox10060923
doi: 10.3390/antiox10060923
pmc: PMC8228070
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : European Regional Development Fund
ID : AIIHHP: CZ.02.1.01/0.0/0.0/16_025/0007428
Organisme : Ministerstvo Zdravotnictví Ceské Republiky
ID : 00023736
Organisme : Ministerstvo Zdravotnictví Ceské Republiky
ID : NV18-08-00149
Organisme : European Regional Development Fund
ID : CZ.2.16/3.1.00/24001
Références
Cardiovasc Diagn Ther. 2017 Dec;7(Suppl 3):S207-S218
pubmed: 29399524
Arterioscler Thromb Vasc Biol. 2009 May;29(5):712-7
pubmed: 19286636
Free Radic Biol Med. 1995 Apr;18(4):815-21
pubmed: 7750804
PLoS One. 2020 Jan 29;15(1):e0227543
pubmed: 31995579
Antioxidants (Basel). 2019 Oct 19;8(10):
pubmed: 31635102
Int J Mol Sci. 2019 Jul 24;20(15):
pubmed: 31344980
Cardiovasc Res. 2002 Aug 15;55(3):438-55
pubmed: 12160941
J Thromb Thrombolysis. 2015 May;39(4):532-5
pubmed: 25169134
Cardiovasc Hematol Agents Med Chem. 2008 Jul;6(3):206-11
pubmed: 18673234
Arterioscler Thromb Vasc Biol. 2004 Sep;24(9):1558-66
pubmed: 15217804
J Clin Med. 2017 Feb 20;6(2):
pubmed: 28230726
J Thromb Haemost. 2006 May;4(5):1029-36
pubmed: 16689755
Biophys J. 2012 Dec 5;103(11):2399-407
pubmed: 23283239
Pol Arch Intern Med. 2017 Dec 22;127(12):873-881
pubmed: 29225327
Blood. 2009 Nov 5;114(19):4272-8
pubmed: 19690336
J Thromb Thrombolysis. 2011 May;31(4):507-13
pubmed: 21221717
J Clin Pathol. 1983 Jun;36(6):712-5
pubmed: 6853736
Clin Appl Thromb Hemost. 2010 Feb;16(1):51-9
pubmed: 19903699
J Thromb Haemost. 2014 Nov;12(11):1776-87
pubmed: 25213262
Dokl Biochem Biophys. 2019 May;484(1):37-41
pubmed: 31012009
Stroke. 2006 Aug;37(8):2086-93
pubmed: 16794209
Stroke. 2009 Apr;40(4):1499-501
pubmed: 19246700
Curr Pharm Des. 2018;24(20):2322-2325
pubmed: 30051777
J Pharmacol Exp Ther. 1989 Jul;250(1):154-61
pubmed: 2746495
Biochimie. 1997 Jul;79(7):449-55
pubmed: 9352095
Free Radic Res. 2002 Mar;36(3):265-8
pubmed: 12071344
Arterioscler Thromb Vasc Biol. 2020 Mar;40(3):554-569
pubmed: 31914791
Curr Neurovasc Res. 2015;12(1):31-9
pubmed: 25557378
Free Radic Res. 2018 Jan;52(1):14-38
pubmed: 29284315
Thromb Res. 2007;121(2):163-74
pubmed: 17467041
Dis Markers. 2018 Aug 7;2018:6138124
pubmed: 30159103
Free Radic Biol Med. 2013 Dec;65:411-418
pubmed: 23851017
ScientificWorldJournal. 2013 Oct 21;2013:359621
pubmed: 24235886
Circ Res. 2016 Aug 19;119(5):e39-75
pubmed: 27418630
Atherosclerosis. 2008 Feb;196(2):551-7
pubmed: 17640649
Arterioscler Thromb Vasc Biol. 2014 Jul;34(7):1355-61
pubmed: 24790138
J Cardiovasc Pharmacol. 2009 Jan;53(1):24-9
pubmed: 19129740
Metabolism. 2006 Jul;55(7):935-9
pubmed: 16784967
Arterioscler Thromb Vasc Biol. 2010 Jan;30(1):75-9
pubmed: 19815816
Stroke. 1973 May-Jun;4(3):400-5
pubmed: 4713027
Sci Rep. 2019 Apr 25;9(1):6573
pubmed: 31024058
Dokl Biochem Biophys. 2017 May;474(1):173-177
pubmed: 28726089
Subcell Biochem. 2017;82:405-456
pubmed: 28101869
Sci Rep. 2019 Dec 13;9(1):19097
pubmed: 31836843
Biophys Chem. 2004 Dec 20;112(2-3):267-76
pubmed: 15572258
Int J Diabetes Dev Ctries. 2010 Jan;30(1):49-51
pubmed: 20431807
J Biol Chem. 2004 Mar 5;279(10):8820-6
pubmed: 14681238
Metabolites. 2020 May 19;10(5):
pubmed: 32438592
Stroke. 1971 Jan-Feb;2(1):81-7
pubmed: 5112008
Int J Biol Macromol. 2018 Mar;108:1028-1034
pubmed: 29137999
Transfus Apher Sci. 2008 Feb;38(1):15-23
pubmed: 18282807
Neural Regen Res. 2018 Dec;13(12):2119-2128
pubmed: 30323140